Medical disclaimer: This page is for educational purposes only. It does not constitute medical advice. Please consult a qualified doctor before making any healthcare decisions. Last reviewed May 2026 by Dr. Kunal Waghray, MD DM DNB MNAMS EDRM.
Bronchoscopy for Central Airway Obstruction in Hyderabad
When a tumour or stricture narrows the trachea or a main bronchus past a critical threshold, breathing becomes laboured at rest. The window for intervention is narrow, and it closes faster than most patients or families expect.
Bronchoscopic treatment can reopen that airway in a single session, performed through the mouth without any chest incision. Dr. Kunal Waghray, MD DM DNB MNAMS EDRM, an interventional pulmonologist in Hyderabad trained at Amrita Institute of Medical Sciences, Kochi, performs the full range of bronchoscopic interventions for central airway obstruction at Respire Airway Clinics, Basheer Bagh and Jubilee Hills.
What Is Central Airway Obstruction?
Central airway obstruction, or CAO, is a narrowing of more than 50 percent of the internal diameter of the trachea, a main bronchus, the bronchus intermedius, or a lobar bronchus. The obstruction may grow from inside the airway wall (endoluminal), press inward from outside the airway (extrinsic compression), or involve both patterns together (mixed obstruction).
How obstruction progresses
Symptoms begin when the internal lumen narrows below approximately 8 millimetres. At that point, exertional breathlessness appears. When the lumen falls below 5 millimetres, breathlessness occurs at rest. A tumour growing in or around a major airway can reach this critical threshold within days to weeks.
Causes in India
Lung cancer is the most common cause of malignant CAO. Squamous cell carcinoma is the single most frequent cell type, because it tends to grow centrally within the airway wall. Oesophageal carcinoma and lymphoma compressing the central airways from enlarged mediastinal nodes are other malignant causes.
In India, post-tuberculosis airway stenosis is a clinically important benign cause. Active or previously treated TB can cause granulomatous inflammation that scars and narrows the trachea or bronchi over months to years. Post-intubation tracheal stenosis is the other common benign cause, developing weeks to months after prolonged mechanical ventilation.
Symptoms: How CAO Differs from Other Breathlessness
The pattern of symptoms in CAO is distinct from the breathlessness of asthma or COPD. Recognising this distinction prompts the right referral.
Stridor
A high-pitched, harsh breathing sound produced by turbulent airflow through a narrowed central airway. Heard during inhalation and sometimes during exhalation. Its presence points to a fixed obstruction at the larynx, trachea, or main bronchus, not to reversible bronchoconstriction.
Haemoptysis
Coughing up blood accompanies many endobronchial tumours. The tumour surface bleeds easily from mucosal invasion. Haemoptysis combined with progressive breathlessness is a strong signal to investigate the central airways urgently.
Post-obstructive pneumonia
When a blocked airway prevents secretions and inhaled bacteria from clearing, the lung tissue behind the obstruction becomes repeatedly infected. Recurrent pneumonia in the same lobe, not responding fully to antibiotics, should prompt CT evaluation of the airway.
Orthopnoea
An inability to lie flat without worsening breathlessness. It reflects severe restriction of airflow in the central airway that worsens when the patient is supine.
Bronchoscopic Treatment Options for CAO
The choice of technique depends on whether the obstruction is endoluminal, extrinsic, or mixed. Endoluminal tumours respond to debulking; extrinsic compression responds better to dilation and stenting; mixed obstruction usually requires a combination of both approaches.
Mechanical debulking
Endoluminal tumourA rigid bronchoscope is advanced into the airway, and its bevelled tip is used to core out and remove tumour tissue from the lumen. This provides immediate airway opening in a single manoeuvre, making it the fastest technique for critical obstruction. It is typically the first step in a multi-tool session.
Nd:YAG laser resection
Exophytic tumour, haemostasisThe Nd:YAG laser delivers a focused beam of energy through a fibre passed down the bronchoscope. It cuts, vapourises, and coagulates tumour tissue simultaneously. Laser resection is particularly precise for exophytic tumour and effective for controlling bleeding from the tumour surface.
Argon plasma coagulation (APC) and electrocautery
Residual tumour, bleedingArgon plasma coagulation uses ionised argon gas to conduct electrical energy across the airway surface without direct tissue contact. Well suited for treating flat or superficial tumour remnants after debulking and for coagulating bleeding areas. Electrocautery uses direct electrical current via a probe to achieve similar coagulation and tissue removal.
Cryotherapy
Adjunct, residual tumourA cryoprobe passed through the bronchoscope freezes tumour tissue by applying extreme cold at its tip. Freezing causes cell death by ice crystal formation within the tissue. Cryotherapy is a slower technique, with full necrotic sloughing occurring over one to two weeks, making it most useful as an adjunct for reducing residual tumour burden.
Balloon dilation
Benign stenosisFor tight strictures, a balloon catheter is passed through the bronchoscope and positioned across the narrowing. The balloon is inflated to stretch the obstructed segment open. Used for post-TB strictures and post-intubation stenosis, often followed by stenting to maintain patency.
Airway stenting
Extrinsic compression, recurrent stenosisA bronchial stent — either a silicone tube or a self-expanding metallic stent — is deployed across the obstruction to hold the airway open. Stents are the primary treatment for extrinsic compression. They are also used after debulking of mixed obstructions to prevent rapid regrowth from narrowing the lumen again.
More on airway stenting→How the Procedure Is Performed
Most bronchoscopic CAO treatments are performed under general anaesthesia or deep sedation. This allows the airway team to work without the patient's reflexes interfering during the procedure.
For endoluminal tumours requiring debulking, laser, or cryotherapy, a rigid bronchoscope is generally preferred. The rigid scope has a wide internal channel that allows multiple instruments to be used simultaneously, permits ventilation through the scope barrel, and provides a stable platform for forceful mechanical debulking. A flexible bronchoscope is often passed through the rigid barrel to reach more distal airways or inspect sites beyond the reach of the rigid instrument.
For less severe or more peripheral strictures, flexible bronchoscopy with balloon dilation or cryotherapy can be performed under moderate sedation. The procedure is performed through the mouth. There are no external incisions. Patients are typically monitored for 24 to 48 hours after the session and discharged once stable.
A staged approach, with a second bronchoscopy scheduled one to two weeks later, is sometimes used when cryotherapy is part of the plan, to remove necrotic tissue from the initial freeze.
“When a patient comes to us with a CT showing the trachea narrowed down to a slit by tumour, the first question is how quickly we can get them into the bronchoscopy suite. We are not waiting on radiation to take effect over weeks. The airway needs to be opened now, and that is what a rigid bronchoscope and the right tools can do in one session.”
Outcomes and Palliative Benefit
A multicentre study published in Chest (Ost et al., 2015; PMCID: PMC4420181) evaluated 1,115 bronchoscopic procedures across 15 centres. Technical success, defined as meaningful restoration of airway patency, was achieved in 93 percent of procedures. Clinically significant improvement in dyspnoea was documented in 48 percent of patients measured.
An observational study from a tertiary care centre in Lucknow, India, published in Lung India (Khan et al., 2020; PMCID: PMC7065553), assessed 152 rigid bronchoscopy procedures in 121 patients. The mean mMRC dyspnoea score fell from 3.9 before the procedure to 1.42 after it. Quality-of-life scores improved from 2.06 to 8.7 on the VAS scale. There was zero procedural mortality across all 152 procedures.
For patients with malignant CAO, bronchoscopic treatment is not intended to replace chemotherapy or radiotherapy. Its role is to restore adequate airflow so that oncology treatment can proceed. A patient with severe breathlessness from tumour-related obstruction may be too compromised to tolerate systemic therapy. Reopening the airway first changes what is clinically possible.
These figures apply to published populations. Individual outcomes vary with the cause of obstruction, technique used, underlying disease trajectory, and follow-up adherence. No outcome can be guaranteed in advance.
Frequently Asked Questions
What is central airway obstruction?
Central airway obstruction is a narrowing of more than 50 percent of the internal diameter of the trachea, main bronchi, or lobar bronchi. It may be caused by a tumour growing inside the airway, external compression from a mass or lymph nodes, or post-treatment scarring.
Is central airway obstruction life-threatening?
Yes. When the tracheal or bronchial lumen narrows severely, airflow drops to a point where the body cannot maintain adequate oxygenation at rest. Untreated critical obstruction can progress to respiratory failure. Prompt referral to an interventional pulmonologist is essential when CAO is identified on imaging.
Can bronchoscopy treat airway obstruction without surgery?
Yes. Therapeutic bronchoscopy uses a rigid or flexible bronchoscope passed through the mouth. The interventional pulmonologist can debulk tumour, apply laser or APC, use cryotherapy, or place a stent — all without any external incision or entry into the chest.
What is bronchoscopic debulking?
Mechanical debulking uses the bevelled tip of a rigid bronchoscope to remove tumour tissue from the airway lumen physically. This provides immediate relief of critical obstruction within the same session. It is often combined with laser or APC to coagulate cut surfaces and reduce bleeding.
Can post-TB airway narrowing be treated bronchoscopically?
In many cases, yes. Post-tuberculosis tracheal or bronchial stenosis can be treated with bronchoscopic balloon dilation, laser resection of granulation tissue, or stent placement to hold the expanded segment open. Multiple sessions may be needed depending on the length and severity of the stricture.
What is the difference between central and peripheral airway obstruction?
Central obstruction affects the trachea, main bronchi, bronchus intermedius, or lobar bronchi — the large proximal airways. Peripheral obstruction affects smaller, more distal airways. Central obstruction is more immediately dangerous because it compromises airflow to entire lungs or large lobes, not isolated segments.
How long does an airway stent procedure take?
Stent placement via bronchoscopy typically takes between 30 and 60 minutes depending on the site and complexity of the obstruction. It is performed under general anaesthesia. Most patients are observed for 24 to 48 hours and then discharged.
Clinical References
- Ost DE, et al. Therapeutic Bronchoscopy for Malignant Central Airway Obstruction: Success Rates and Impact on Dyspnea and Quality of Life. Chest. 2015. PMCID: PMC4420181. PMID: 25358019.
- Khan A, et al. Rigid bronchoscopic interventions for central airway obstruction: an observational study. Lung India. 2020. PMCID: PMC7065553. PMID: 32108594.